✓ Medically reviewed by  ·  Last reviewed: May 2026

Morgan Ellis

Pharmacy Researcher · 8 years experience

Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.

Peptide Blends Explained: BPC-157 + TB-500, Peptide Healing Stack, and GLOW Blend Compared

Three pre-bundled multi-peptide products on the MedsBase catalogue address common combination-research scenarios. Each blend pre-mixes complementary mechanism arms into a single lyophilized vial, simplifying reconstitution and reducing per-vial cost compared with sourcing the components separately. This guide covers what each blend contains, when blends are the right choice vs separate vials, and the reconstitution math for multi-component products.

The three blends on the catalogue

BPC-157 + TB-500 Blend

BPC-157 + TB-500 Blend contains the classical tissue-repair pairing: BPC-157 (body-protection-compound fragment with multi-pathway tissue-repair mechanism) plus TB-500 / thymosin β-4 (actin-binding tissue-repair compound). The two molecules cover complementary tissue-repair mechanism arms — BPC-157 acts on local growth-factor signalling and angiogenesis at the injury site, TB-500 acts systemically on actin polymerization and cell migration. The combination is the most-published tissue-repair stack in the peptide research literature.

Composition: typically 5 mg BPC-157 + 5 mg TB-500 per vial. Lyophilized; reconstitute with BAC water.

Best for: tendon / ligament / orthopaedic-repair research protocols where the synergistic mechanism is the design point. See BPC-157 vs TB-500 for the standalone-comparison context.

Peptide Healing Stack (BPC + TB + BAC Water)

Peptide Healing Stack bundles BPC-157 + TB-500 with bacteriostatic water for reconstitution included. The composition is similar to the BPC + TB Blend but with the BAC water co-shipped, addressing the practical issue that researchers often forget to order the diluent separately.

Composition: BPC-157 + TB-500 (proportions match the BPC + TB Blend) + 10 mL BAC water reconstitution vehicle.

Best for: first-time researchers in the tissue-repair cluster who need everything in one shipment; budget-conscious research protocols where the bundle pricing produces savings vs separate ordering.

GLOW Blend (BPC + GHK-Cu + TB-500)

GLOW Blend bridges the tissue-repair cluster with the cosmetic-collagen cluster by adding GHK-Cu (copper tripeptide with collagen-synthesis and hair-follicle mechanism) to the BPC-157 + TB-500 pairing. The blend addresses research scenarios where both tissue-repair and cosmetic-collagen endpoints are measured in the same experimental design.

Composition: 10 mg BPC-157 + 50 mg GHK-Cu + 10 mg TB-500 per vial. Lyophilized; reconstitute with BAC water.

Best for: wound-healing research where matrix-remodelling and tissue-repair endpoints are both primary; dermatologic regeneration protocols; post-procedural recovery research where both endpoint families are tracked.

Comparison table

Reconstitution math for blends

Reconstitution of a blend is procedurally identical to single-peptide reconstitution, with one additional calculation: each component’s concentration is calculated separately from its labelled per-vial mass.

Worked example: GLOW Blend (BPC 10 mg + GHK-Cu 50 mg + TB-500 10 mg per vial) reconstituted with 3 mL BAC water:

• BPC-157 concentration = 10 mg ÷ 3 mL = 3.33 mg/mL = 3333 mcg/mL
• GHK-Cu concentration = 50 mg ÷ 3 mL = 16.67 mg/mL = 16667 mcg/mL
• TB-500 concentration = 10 mg ÷ 3 mL = 3.33 mg/mL = 3333 mcg/mL

If you draw 10 IU on a 100-unit insulin syringe (= 0.1 mL of solution), you administer:

• 333 mcg BPC-157
• 1667 mcg GHK-Cu
• 333 mcg TB-500

The ratio between components is fixed by the blend composition — you can’t adjust individual component doses without changing the volume drawn (which changes all three doses proportionally). This is the fundamental trade-off of blends vs separate vials: blends are simpler operationally but lock the component ratio at the manufacturer-specified proportion.

When to pick blends vs separate vials

Pick blends when:

• The component ratio in the blend matches your research-protocol design
• Operational simplicity matters (one vial vs three; one set of reconstitution math)
• Per-vial cost is a consideration (blends are typically less expensive than separate ordering)
• First-time researcher in the cluster who wants the canonical reference combination

Pick separate vials when:

• You need to vary individual component doses independently (e.g., higher BPC-157 with same TB-500)
• Your protocol uses one component at substantially different schedule from the others (e.g., BPC continuous, TB-500 every-other-day)
• You’re stacking with additional components not in the blend (e.g., adding KPV to a BPC + TB protocol)
• Your research design needs dose-ranging on a single component

What blends don’t do

• Blends don’t change the pharmacology of the individual components. A BPC-157 + TB-500 blend is mechanistically identical to BPC-157 alone plus TB-500 alone administered simultaneously. The blend is a packaging convenience, not a different molecule or different mechanism.
• Blends don’t introduce new mechanism interactions beyond the standalone combination. The published research on BPC-157 + TB-500 (whether from the blend product or from separately-administered components) shows the same complementary tissue-repair mechanism arms.
• Blends don’t substitute for protocol expertise. Using a blend doesn’t eliminate the need to understand each component’s mechanism, dosing range, side-effect profile, and research applicability.

FAQ

Is the BPC + TB blend mechanistically different from BPC + TB administered separately?

No. The mechanism is the complementary tissue-repair pairing regardless of whether the components are pre-mixed (blend) or separately reconstituted and administered together. The blend is a packaging convenience and per-vial cost reduction; the pharmacology is identical.

Can I draw the components at different ratios from a blend?

No — the component ratio is fixed by the manufacturer composition. Drawing more volume increases all components proportionally; drawing less decreases all components proportionally. To vary the ratio, source the components as separate vials.

How do I reconstitute the GLOW Blend?

BAC water at the volume that produces clean dose-math for your research-protocol design. Typical: 3 mL BAC water for a 10/50/10 mg vial gives concentrations of 3.33 / 16.67 / 3.33 mg/mL respectively. Each 10 IU drawn delivers 333 mcg BPC-157 + 1667 mcg GHK-Cu + 333 mcg TB-500.

Why is the GHK-Cu component 5x larger than the BPC-157 component in GLOW?

Because the typical research-dose ratio favours higher GHK-Cu doses. GHK-Cu cosmetic-research protocols use mg-range topical / SC doses; BPC-157 and TB-500 use hundreds-of-mcg per administration. The 50:10:10 composition matches typical relative dose ranges.

Can I add my own peptide to a blend?

For research-protocol blend designs, yes — the question is whether the additional peptide is pharmacokinetically compatible with the blend components. Most synthetic peptides at the typical research concentrations don’t show problematic interactions; recombinant proteins or substantially different pH-sensitivity molecules may have stability concerns. Source separately rather than ad-hoc combining if uncertain.

Storage protocol for blends?

Same as single peptides: lyophilized vials at -20 °C long-term or 2-8 °C as working stock; reconstitute with BAC water; reconstituted solution at 2-8 °C with use within ~30 days; protect from light; never freeze-thaw.

Bottom line

The three peptide blends on the MedsBase catalogue pre-mix complementary mechanism arms for the most-published combination-research scenarios: classical tissue repair (BPC + TB Blend), all-in-one tissue-repair shipment (Peptide Healing Stack), and bridged repair + cosmetic-collagen (GLOW Blend). Blends offer operational simplicity and per-vial cost savings; separate vials offer protocol-design flexibility. Reconstitution math is identical to single peptides but applied per-component. Pick based on whether your research-protocol design matches the fixed component ratios in the blend or requires independent component-dose adjustment.

Written by

Sophie Chen

Pharmaceutical Content Researcher · 8 years experience

Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.